Among the Covid-19 vaccine plays, Sorrento (SRNE) snuck in to cheat investors. Look at prior to 2020. In the last three years, the company did nothing but raise capital, issue stock, and burn money. They debt is piling up.Data courtesy of Stock rover. Create a free account to access full financial bar charts!Look for another cash raise as the firm desperately seeks capital. The company MUST produce Covid-19 COVI-GUARD data that validates its efficacy and safety.Sell this stock.Get access to T2BF and up to $100,000 in capital.